SCHEMBL16307178

SCHEMBL16307178

CNC(=O)c1ccc(-c2cnc3c(NCCC(F)(F)F)cc(C(=O)c4cccc(F)c4)nn23)cc1C

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TTK P33981 20/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16307179 0.93 TTK (0.67) TTK
SCHEMBL15271237 0.92 TTK (0.79) TTK
SCHEMBL15583056 0.92 TTK (0.64) TTK
SCHEMBL15271551 0.86 TTK (0.80) TTK
SCHEMBL459219 0.84 TTK (0.63) TTK
SCHEMBL15583054 0.84 TTK (0.64) TTK
SCHEMBL15271383 0.83 TTK (0.80) TTK
SCHEMBL17416352 0.82 TTK (0.59) TTK
SCHEMBL15271250 0.81 TTK (0.76) TTK
SCHEMBL15555880 0.81 TTK (0.68) TTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014198776-A1 COMBINATION OF A IMIDAZOPYRIDAZINE DERIVATIVE AND A MITOTIC AGENT FOR THE TREATMENT OF CANCER BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-12-18 WO disclosed